Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 25

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

288

HTML

2112

Figures (1-3)

147

Tables (1-4)

140

Sum=2687

Jul 7, 2006 (publication date) through Jul 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Jul 7, 2006; 12(25): 4038-4043
Published online Jul 7, 2006. doi: 10.3748/wjg.v12.i25.4038

Table 4 Inflammatory degree and degeneration degree of hepatocytes in HBV-Tg liver after 10 wk of treatment (mean ± SD, n = 5)

	0 wk	10 wk
Degeneration degree of hepatocytes	8.00 ± 0.63	5.60 ± 0.68^b
Inflammation degree of hepatocytes	5.20 ± 0.37	4.00 ± 0.32^a

^aP < 0.05, ^bP < 0.01 vs T0 in one group.

Citation: Wang R, Du ZL, Duan WJ, Zhang X, Zeng FL, Wan XX. Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata. World J Gastroenterol 2006; 12(25): 4038-4043
URL: https://www.wjgnet.com/1007-9327/full/v12/i25/4038.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i25.4038